Clinical Research Directory
Browse clinical research sites, groups, and studies.
18F-Pentixafor PET in Hematologic Malignancies
Sponsor: First Affiliated Hospital of Zhejiang University
Summary
The aim of this study is to evaluate the efficacy of 18F-Pentixafor PET imaging in the diagnosis, staging and response evaluation of hematological malignancies.
Official title: Prospective Clinical Study of 18F-Pentixafor PET Imaging in Hematologic Malignancies
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2025-07-01
Completion Date
2029-12
Last Updated
2025-08-14
Healthy Volunteers
No
Conditions
Interventions
18F-Pentixafor
Patients with hematological malignancies receive 55 MBq/kg of 18F-Pentixafor intravenously followed by PET/CT or PET/MR after 60min of injection.
Locations (1)
The First Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China